Cefquinome sulfate

CAS : 118443-89-3

Ref. 3D-AC19869

Informations sur le produit

• Nom: Cefquinome sulfate
• Synonymes: 1-[[(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]m ethyl]-5,6,7,8-tetrahydro-quinolinium sulfateCefquinome sulphateHR 111V sulfate, (6R,7R)-7-(((2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-8-oxo-3-(5,6,7,8-tetrahydro-1-quinoliniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Sulfate, (6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-3-(5,6,7,8-tetrahydroquinolinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate sulfate (1:1), HR 111V sulfate

Description

Cefquinome sulfate is an injectable solution of cefquinome, a bactericidal agent. This antimicrobial agent inhibits bacterial growth by disrupting the cell membrane, causing cell lysis and death. Cefquinome sulfate can be used for the treatment of infectious diseases caused by Gram-positive bacteria such as Staphylococcus aureus and Streptococcus pneumoniae. The chemical stability of this compound is high, with no loss during storage at room temperature or in various solvents. Cefquinome sulfate has been shown to have antibacterial efficacy against a wide range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) isolates and Clostridium difficile strains resistant to vancomycin or metronidazole.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 626.69 g/mol
• Formule: C₂₃H₂₆N₆O₉S₃
• Degré de pureté: Min. 95%
• Couleur/Forme: White To Light (Or Pale) Yellow To Beige To Light Brown Solid